Skin disorders
23 results
Applied filters
Valaciclovir for shingles
1 February 2024SPS PGD template for supply of valaciclovir for shingles in specified patient groups.
Using potassium permanganate for skin conditions or wound care
4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.
Using inhaled or topical corticosteroids during breastfeeding
17 July 2023All topical and inhaled corticosteroids can be used while breastfeeding; there is no preferred choice. Recommendations apply to full term, healthy infants only.
Treating lice during breastfeeding
31 May 2024Wet combing, dimeticone, malathion or permethrin can be used during breastfeeding; choice will depend on the indication. Other treatments can be considered.
Treating impetigo topically during breastfeeding
21 March 2024Fusidic acid, hydrogen peroxide or mupirocin can be used topically during breastfeeding. Recommendations apply to full term and healthy infants.
The licence and supporting evidence for ustekinumab biosimilars
2 August 2024Ustekinumab biosimilars (Pyzchiva, Steqeyma, Uzpruvo, Wezenla) are licensed. Learn about indications, formulations, supporting evidence and differences.
The licence and supporting evidence for omalizumab biosimilar
19 September 2025We highlight evidence for licensed omalizumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Xolair).
Preparing to use ustekinumab biosimilar
16 July 2024Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
Preparing to use omalizumab biosimilar
19 September 2025Omalizumab biosimilars are expected soon. We offer general information and implementation advice.
Permethrin for scabies
27 November 2025SPS PGD template for supply of permethrin for the treatment of scabies in specified patient groups.